Tag: Pharmaceutical Industry
Revolutionizing Protein Therapeutics: InduPro Secures $85M Funding, Names Prakash Raman as...
InduPro, a biotechnology company focused on developing novel therapeutics for cancer and autoimmune diseases, recently secured $85 million in funding through a Series A...
Olema Pharmaceuticals Stock (OLMA) Up 2.3% in NASDAQ Trading
Olema Pharmaceuticals, Inc. (OLMA) experienced a 2.3% increase in its stock price during mid-day trading on Friday. The stock reached a high of $12.75...
Rigel’s Five Presentations at EHA2024: Key Highlights and Insights
Rigel Pharmaceuticals, Inc. presented five key presentations at the European Hematology Association (EHA) 2024 Hybrid Congress in Madrid, Spain. One oral presentation and four...
Streamlining Compliance: Successful Adoption in the Pharmaceutical Industry – A Case...
Streamlining Compliance: Successful Adoption in the Pharmaceutical Industry - A Case StudyCompliance management is a critical yet complex aspect of business operations, particularly in...
Psychedelic Stocks Tank After FDA Advisors Shoot Down MDMA Therapy For...
Psychedelic Stocks Plummet After FDA Advisors Reject MDMA Therapy for PTSDTopline
Shares for companies specializing in psychedelic medicines took a nosedive during premarket trading following...
FDA approves Moderna’s RSV vaccine, its second licensed product
FDA Approves Moderna’s RSV Vaccine, Its Second Licensed ProductThe Food and Drug Administration has given the green light to Moderna’s latest vaccine aimed at...
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
FDA Approves Moderna's RSV Vaccine for Seniors, the Company's Second-Ever ProductThe Food and Drug Administration has given the green light to Moderna's RSV vaccine...
FDA approves Moderna’s mRNA RSV vaccine
FDA approves Moderna’s mRNA RSV vaccineThe Food and Drug Administration (FDA) has given the green light to Moderna’s RSV mRNA vaccine for adults over...
US FDA Approves Moderna’s RSV Vaccine
US FDA Approves Moderna's RSV VaccineThe US Food and Drug Administration has given the green light to Moderna's respiratory syncytial virus (RSV) vaccine, marking...
Lilly Announces Details of Presentations at 2024 American Society of Clinical...
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingEli Lilly and Company have shared exciting news about their...